Gillian M. Duchesne

2 St Andrews Place
East Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Overcoming uncertainty: A framework to guide the implementation of Australian radiation therapy advanced practitioners.

Overcoming uncertainty: A framework to guide the implementation of Australian radiation therapy advanced practitioners.

Journal: Journal of medical radiation sciences

Published: May 28, 2023

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system.

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system.

Journal: Cancer

Published: March 10, 2023

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.

Journal: Pathology

Published: November 07, 2021

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy.

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy.

Journal: JNCI cancer spectrum

Published: August 10, 2021

Navigating uncertainty: The implementation of Australian radiation therapy advanced practitioners.

Navigating uncertainty: The implementation of Australian radiation therapy advanced practitioners.

Journal: Technical innovations & patient support in radiation oncology

Published: September 28, 2020

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.

Journal: The Lancet. Oncology

Published: April 24, 2020

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial.

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial.

Journal: Histopathology

Published: January 05, 2020

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.

Journal: International journal of radiation oncology, biology, physics

Published: November 17, 2019

Effective and well tolerated: where do these drugs fit now?

Effective and well tolerated: where do these drugs fit now?

Journal: The Lancet. Oncology

Published: November 25, 2018

Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma.

Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma.

Journal: Journal of medical imaging and radiation oncology

Published: October 06, 2018

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.

Journal: The Lancet. Oncology

Published: August 20, 2018

Using Online Meeting Software to Facilitate Geographically Dispersed Focus Groups for Health Workforce Research.

Using Online Meeting Software to Facilitate Geographically Dispersed Focus Groups for Health Workforce Research.

Journal: Qualitative health research

Published: June 19, 2018

Showing 1-12 of 57

Last Updated: 09/26/2026